COVID-19 patients have two treatment options that can be taken at home. But that convenience comes with a catch: The pills have to be taken as soon as possible once symptoms appear.
Merck’s Lagevrio is not authorized for children because it might interfere with bone growth. It also isn’t recommended for pregnant women because of the potential for birth defects.
Pfizer’s pill isn’t recommended for patients with severe kidney or liver problems. It also may not be the best option for some because it may interact with other medications.WHAT’S THE TREATMENT WINDOW? The pills have to be started as soon as possible, within five days of the start of symptoms. Cough, headache, fever, the loss of taste or smell and muscle and body aches are among the more common signs. The Centers for Disease Control and Prevention offers aDr. Cameron Wolfe, an infectious disease specialist at Duke University Hospital, advises getting a test as soon as you have symptoms of COVID-19.
“If you wait until you have started to get breathless, you have already to a large extent missed the window where these drugs will be helpful,” Wolfe said.Pharmacies, community health centers, hospitals and urgent care centers are among the sites stocking the antiviral pills, but prescriptions must come from a doctor or other authorized health worker.
The oral treatments are currently available in about 20,000 locations around the country, but President Joe Biden’s administration expects that total to jump to around 40,000 in the next few weeks.The administration also is working to expand the number of sites that can test patients and then provide the treatments in one visit. There are currently 2,200 of these so-called test-to-treat sites, including all 1,200 MinuteClinic locations inside CVS drugstores.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
FDA approves COVID drug for children, China deals with uphill COVID battle, and more COVID newsThe US Food and Drug Administration announced Monday that it has expanded approval of the COVID-19 drug remdesivir to treat patients as young as 28 days old. Here's that and more COVID news.
Baca lebih lajut »
Beijing locks down some areas as COVID-19 cases mountChina's capital, Beijing, began mass testing of more than 3 million people on Monday and restricted residents in one part of the city to their compounds, sparking worries of a wider Shanghai-style lockdown. While only 70 cases have been found so far in the city of more than 21 million since a new outbreak surfaced Friday, authorities have rolled out strict measures under China's “zero-COVID” approach to try to prevent a further spread of the virus. Shanghai, which has been locked down for more than two weeks, reported more than 19,000 new infections and 51 deaths in the latest 24-hour period, pushing its announced death toll from the ongoing outbreak to 138.
Baca lebih lajut »
Americans who haven't had COVID-19 are now in the minority following omicron surge
Baca lebih lajut »
Vice President Harris has tested positive for COVID-19Vice President Harris has tested positive for COVID-19 and has exhibited no symptoms, the White House announced on Tuesday. She's not considered a close contact to President Biden or the first lady.
Baca lebih lajut »
Djokovic Can Play Wimbledon After Covid-19 Vaccination Requirement DroppedThe tennis star was unable to compete in the Australian Open after his visa was canceled on the grounds that allowing him to remain in the country would risk promoting anti-vaccine sentiments.
Baca lebih lajut »
Beto O’Rourke tests positive for COVID-19The Democratic candidate for governor is experiencing mild symptoms and “will be...
Baca lebih lajut »